Wamilda, Jerillo R.
HRN: 28-56-01 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/11/2026
02/11/2026
IVT
1GM
ON CALL TO OR
LTCS
Checking Initial Appropriateness